Related Experiment Video
Updated: Apr 21, 2026

Defining Gene Functions in Tumorigenesis by Ex vivo Ablation of Floxed Alleles in Malignant Peripheral Nerve Sheath Tumor Cells
Published on: August 25, 2021
Abstract:
Genetic inactivation of PRC2 components, NF1, and CDKN2A are frequently detected in MPNSTs.
Insights
Genetic inactivation of Polycomb Repressive Complex 2 (PRC2) components, Neurofibromatosis type 1 (NF1), and Cyclin Dependent Kinase Inhibitor 2A (CDKN2A) are common in malignant peripheral nerve sheath tumors (MPNSTs). These genetic alterations are key drivers in MPNST development.
Area of Science:
- Oncology
- Cancer Genetics
- Molecular Biology
Background:
- Malignant peripheral nerve sheath tumors (MPNSTs) are aggressive cancers arising from nerve cells.
- Understanding the genetic underpinnings of MPNSTs is crucial for developing targeted therapies.
Purpose of the Study:
- To identify frequently inactivated genes in MPNSTs.
- To investigate the role of PRC2 components, NF1, and CDKN2A in MPNST pathogenesis.
Main Methods:
- Analysis of genetic alterations in MPNST patient samples.
- Utilizing genomic sequencing and molecular profiling techniques.
Main Results:
- Frequent genetic inactivation of Polycomb Repressive Complex 2 (PRC2) components was observed.
- Inactivation of Neurofibromatosis type 1 (NF1) and Cyclin Dependent Kinase Inhibitor 2A (CDKN2A) genes were also frequently detected.
Conclusions:
- Genetic inactivation of PRC2, NF1, and CDKN2A are significant events in MPNST development.
- These genetic alterations represent potential therapeutic targets for MPNST treatment.
More Related Videos
09:33Author Spotlight: Finding New Therapeutic Targets for Malignant Peripheral Nerve Sheath Tumor Through Genome-Scale shRNA Screens
Published on: August 25, 2023
08:57Author Spotlight: Genetically Engineered Mouse Models and Pathological Characterization of Neurofibromatosis Type 1 Associated Tumors
Published on: May 17, 2024
Related Concept Videos
Abnormal Proliferation
The Retinoblastoma Gene
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
Loss of Tumor Suppressor Gene Functions
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
Loss of Tumor Suppressor Gene Functions
Nonsense-mediated mRNA Decay
Usually, Upf3 binds to an Exon Junction Complex (EJC) at mRNA splice sites. If a ribosome fully translates the mRNA,...
Cancer-Critical Genes I: Proto-oncogenes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...